Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Clinical trial NCT07398417 · RECRUITING
Trial details
- NCT number
- NCT07398417
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-14
- Primary completion
- 2028-03-01
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.